ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) is a publicly traded company in the Unknown sector. Across all available filings, 56 corporate insiders have executed 435 transactions totaling $151.9M, demonstrating a bullish sentiment with $69.5M in net insider flow. The most recent transaction on Jun 28, 2024 involved a transaction of 70,055 shares valued at $1.0M.
HRT Insider Activity Summary
Who Is Buying HRT Stock?
No significant insider buying has been recorded for HRT in the recent period.
Who Is Selling HRT Stock?
No significant insider selling has been recorded for HRT in the recent period.
Is ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HRT is bullish with an Insider Alignment Score of 73/100 and a net flow of $69.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
HRT Frequently Asked Questions
Understanding HRT Insider Activity
Insider trading at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 56 insiders are actively trading HRT stock, having executed 435 transactions in the past 90 days. The most active insider is James D. Carey (Executive), who has made 20 transactions totaling $28.2M.
Related Tools
Track ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Insider Activity
Get notified when executives and directors at HRT file new Form 4 transactions